Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys.

Grondin, R; Bédard, P J; Hadj Tahar, A; Grégoire, L; Mori, A; Kase, H

Grondin, R; Bédard, P J; Hadj Tahar, A; Grégoire, L; Mori, A; Kase, H.

Affiliation

Grondin R; Neuroscience Research Unit, Laval University Research Center, Quebec, Canada.

Neurology ; 52(8): 1673-7, 1999 May 12.

Article in En | MEDLINE | ID: mdl-10331698

Subject(s)

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine/adverse effects; Levodopa/pharmacology; Parkinson Disease, Secondary/chemically induced; Purinergic P1 Receptor Antagonists; Purines/pharmacology; Animals; Brain/drug effects; Female; Levodopa/therapeutic use; Locomotion/drug effects; Macaca fascicularis; Parkinson Disease, Secondary/drug therapy; Purines/therapeutic use; Receptor, Adenosine A2A

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease, Secondary / Purines / Levodopa / 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Purinergic P1 Receptor Antagonists Limits: Animals Language: En Journal: Neurology Year: 1999 Type: Article Affiliation country: Canada

Search on Google

XML

PubMed Links